Wound formation, wound size, and progression of wound healing after intratumoral treatment of mast cell tumors in dogs with tigilanol tiglate

BACKGROUND: Tigilanol tiglate (TT) is a novel small molecule for intratumoral treatment of nonmetastatic mast cell tumors (MCTs) in dogs. In a randomized controlled clinical study, 75% of dogs that received a single TT treatment achieved complete resolution of the MCT by 28 days, with no recurrence...

Descripción completa

Detalles Bibliográficos
Autores principales: Reddell, Paul, De Ridder, Thomas R., Morton, John M., Jones, Pamela D., Campbell, Justine E., Brown, Graham, Johannes, Chad M., Schmidt, Peter F., Gordon, Victoria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848365/
https://www.ncbi.nlm.nih.gov/pubmed/33438258
http://dx.doi.org/10.1111/jvim.16009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848365/
https://www.ncbi.nlm.nih.gov/pubmed/33438258
http://dx.doi.org/10.1111/jvim.16009

Ejemplares similares